A new study from Tulane University finds that historical race-based lending practices are still impacting health today, ...

The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

Gilead (GILD) announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV Infection, ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of HIV research findings at the International ...

SYNC, its first homegrown CAR-T therapy, one of the first to show promise in treating certain types of brain cancers. This ...

International migration has become a major global issue generating huge economic, social, and cultural consequences in both countries of origin and countries of destination. Europe has become an ...

Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need ...

Johnson & Johnson announced that the China National Medical Products Administration has approved Teclistamab Injection as a ...

The emergence of psychotic symptoms in patients infected with HIV presents a diagnostic challenge. The clinician should consider a primary psychiatric illness (e.g., schizophrenia or bipolar ...

and 5 trials in key populations across the U.S., U.K., and France. These studies are intended to contribute additional data in communities where the use of or access to prevention options have ...